MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP13862780.7

公开号：

EP2931265B1

申请日:

2013.12.12

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/